Therefore, it is important to take more consideration on levels of BMI, WHR, TC, LDL, FPG, 2hPG, HOMA-IR, APN, and CRP of T2DM patients complicated with NAFLD treated by liraglutide. The gene discussed is ANPEP; the disease is metabolic dysfunction-associated steatotic liver disease.